LA PORTE, Ind. (WNDU) - MonoSol released a statement on Thursday after nearly 200 employees went on strike over a new contract proposal. Employees told 16 News Now earlier this week they’ve been ...
- Strengthening Intellectual Property for Sublingual Delivery of Apomorphine to Treat OFF Episodes in Parkinson`s Disease Patients - TORONTO and WARREN, N.J., April 04, 2016 (GLOBE NEWSWIRE) ...
The company plans to start studies to show that its orally dissolving version of escitalopram oxalate works the same as Lexapro so that MonoSol Rx can submit the drug for marketing approval in the ...
WARREN, N.J., April 25, 2011 /PRNewswire/ -- MonoSol Rx, LLC ("MonoSol Rx"), the developer of PharmFilm® drug delivery technology, today announced that the Company has entered into a development and ...
MonoSol Rx is on a roll. During the span of a month this summer, the tiny Warren-based company announced that two of its drugmaker partners had received regulatory approval to sell reformulated ...
WARREN, N.J., Jan. 4, 2011 /PRNewswire/ -- MonoSol Rx, the developer of PharmFilm® drug delivery technology, and Midatech Group Ltd, a global leader and centre of excellence for the design, ...
Nearly 1,000 people assembled at Valparaiso’s Central Park Plaza for MonoSol’s employee appreciation picnic. MonoSol is a division of Japan’s Kuraray Group. “MonoSol has a deep sense of commitment to ...
MonoSol LLC — riding a wave of growth spurred on by the rapid adoption of water soluble detergent packets in recent years — is looking to the future for its next big hit. The Merrillville, Ind.-based ...
MonoSol LLC has opened a new $95 million plant in Portage, Ind., boosting the company's manufacturing capacity by 15 percent. “Our business is growing. There are huge opportunities for unit-dose ...
Specialty pharmaceutical company will receive an exclusive license to use MonoSol Rx s drug-delivery technology.Adams Respiratory Therapeutics Inc. (Nasdaq: ARxT) has entered into an agreement with ...
WARREN, N.J., Feb. 21 MonoSol Rx, a drug delivery companyspecializing in dissolving thin film pharmaceutical products, today announcedthat it has successfully completed a pilot clinical study for its ...
TORONTO, ONTARIO and WARREN, NEW JERSEY--(Marketwired - Apr 4, 2016) - Cynapsus Therapeutics Inc. ("Cynapsus" or the "Company") (CYNA)(CTH.TO), and MonoSol Rx LLC ("MonoSol Rx") today announced that ...